Browsing by Author "Yao, G.B."
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Item First detailed analysis of predictors of response in HBeAg-negative chronic hepatitis B: Data from a multicenter, randomized, partially double-blind study of peginterferon alfa-2a (40KD) (PEGASYS (R)) alone or in combination with lamivudine vs lamivudine alone(Wiley, 2004-10) Bonino, F.; Lau, G.; Macellin, P.; Hadziyannis, S.; Kitis, G.; Jin, R.; Yao, G.B.; Piratvisuth, T.; Germanidis, G.; Yurdaydın, Cihan; Diago, M.; Lai, M.; McCloud, P.; Brunetto, M.R.; Farci, P.; Gürel, Selim; Uludağ Üniversitesi/Tıp Fakültesi/Gastroenteroloji Bilim Dalı.Item Profound on-treatment viral suppression with peginterferon alfa-2a (40KD) (PEGASYS (R)) plus lamivudine combination therapy limits the development of YMDD mutations, but does not improve sustained response rates over peginterferon alfa-2a (40KD) alone(Wiley, 2004-10) Germanidis, G.; Marcellin, P.; Lau, G.; Bonino, F.; Farci, P.; Hadziyannis, S.; Jin, R.; Yao, G.B.; Piratvisuth, T.; Yurdaydın, C.; Diago, M.; Lai, M.Y.; Popescu, M.; Pluck, N.; Gürel, S.; Uludağ Üniversitesi/Tıp Fakültesi.